Dendroaspis natriuretic peptide is degraded by a metalloproteinase in the rat kidney

Molecular Medicine Reports
Soo Mi KimSung Zoo Kim

Abstract

Our previous study demonstrated that the concentration of dendroaspis natriuretic peptide (DNP) was markedly higher than that of atrial NP (ANP) in rabbit plasma, indicating that DNP has a different metabolic rate from other NPs. Therefore, the metabolic characteristics of DNP in mammals require further analysis. The stabilities of NPs were determined by incubating 125I‑labeled ANP, brain NP (BNP), C‑type NP (CNP) and DNP at 37˚C for 1, 2 and 4 h, and analyzing their profiles by reversed‑phase high‑performance liquid chromatography. 125I‑labeled ANP, BNP and CNP were quickly degraded in rat plasma, while 125I‑labeled DNP was stable for 4 h. The relative stability of the peptides following incubation in rat plasma followed the rank order of: DNP>ANP≥BNP>CNP. Organs were also examined for the degradation of DNP, including the spleen, kidney, liver, heart and lung. The physiological target organ for the degradation of DNP was observed to be the kidney. Furthermore, degradation of DNP in the kidney was attenuated by phenanthroline, a metalloproteinase inhibitor. Therefore, these results indicate that DNP has a longer stability in plasma and that it may have strong therapeutic applications in cardiac disease.

References

Nov 15, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·B J Morris
Oct 1, 1991·Canadian Journal of Physiology and Pharmacology·K NakaoH Imura
Apr 30, 1990·Biochemical and Biophysical Research Communications·T SudohH Matsuo
Nov 30, 1990·Biochemical and Biophysical Research Communications·Y VannesteM Deschodt-Lanckman
Sep 1, 1987·Annals of Clinical Biochemistry·A C TanT J Benraad
Dec 30, 1987·European Journal of Biochemistry·G M OlinsH A Zurcher-Neely
Mar 3, 1988·Nature·T SudohH Matsuo
Apr 15, 1988·Biochemical and Biophysical Research Communications·E L RuggG Cramb
Jan 1, 1988·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·L J JosephR Mathiyarasu
Sep 1, 1995·Current Opinion in Cardiology·A Januszewicz
Jun 5, 2003·Heart Disease·George Stoupakis, Marc Klapholz
Jan 27, 2005·Pharmacology & Therapeutics·Ramona S ScotlandAdrian J Hobbs
Dec 27, 2011·Peptides·Soo Mi KimSung Zoo Kim

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Indian Journal of Endocrinology and Metabolism
Kaushik PanditSubhankar Chowdhury
Cellular & Molecular Biology Letters
M PiechotaJ Rysz
The American Journal of Gastroenterology
E FábregaF Pons-Romero
Clinical Chemistry and Laboratory Medicine : CCLM
Yoshihiro J AkashiStefan D Anker
© 2021 Meta ULC. All rights reserved